Market Overview

Institute for Clinical and Economic Review Says Spark Therapeutics Luxturna Gene Therapy $850K Price Far Too High; Should Be 75%-82% Lower Based On Value Assessment -Reuters

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News

 

Related Articles (ONCE)